BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31573892)

  • 1. Impact of Abuse of Topical Corticosteroids and Counterfeit Cosmetic Products for the Face: Prospective Demographic Study in Basrah City, Iraq.
    Jaccob AA; Yaqoub AA; Rahmani MA
    Curr Drug Saf; 2020; 15(1):25-31. PubMed ID: 31573892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects.
    Ladizinski B; Mistry N; Kundu RV
    Dermatol Clin; 2011 Jan; 29(1):111-23. PubMed ID: 21095535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misuse of Topical Corticosteroids for Cosmetic Purpose in Antananarivo, Madagascar.
    Sendrasoa FA; Ranaivo IM; Andrianarison M; Raharolahy O; Razanakoto NH; Ramarozatovo LS; Rapelanoro Rabenja F
    Biomed Res Int; 2017; 2017():9637083. PubMed ID: 28904977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal.
    Mahé A; Ly F; Aymard G; Dangou JM
    Br J Dermatol; 2003 Mar; 148(3):493-500. PubMed ID: 12653741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical corticosteroids in dermatology.
    Mehta AB; Nadkarni NJ; Patil SP; Godse KV; Gautam M; Agarwal S
    Indian J Dermatol Venereol Leprol; 2016; 82(4):371-8. PubMed ID: 27279294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aesthetic problems associated with the cosmetic use of bleaching products.
    Ly F; Soko AS; Dione DA; Niang SO; Kane A; Bocoum TI; Dieng MT; Ndiaye B
    Int J Dermatol; 2007 Oct; 46 Suppl 1():15-7. PubMed ID: 17919199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical corticosteroid abuse on the face: a prospective, multicenter study of dermatology outpatients.
    Saraswat A; Lahiri K; Chatterjee M; Barua S; Coondoo A; Mittal A; Panda S; Rajagopalan M; Sharma R; Abraham A; Verma SB; Srinivas CR
    Indian J Dermatol Venereol Leprol; 2011; 77(2):160-6. PubMed ID: 21393945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of information and education about topical corticosteroids in dermatology outpatient departments: experience from Turkey.
    Basak PY; Ozturk M; Baysal V
    J Eur Acad Dermatol Venereol; 2003 Nov; 17(6):652-8. PubMed ID: 14761131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid nonprescription use: a cross-sectional hospital-based study in Basrah.
    Mansour AA; Odaa AH; Wanoose HL
    Med Princ Pract; 2010; 19(3):182-7. PubMed ID: 20357499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Knowledge, Cosmetic Interests, Attitude, and the Need for Health Education Regarding the Use of Topical Bleaching Agents Among Women in West Saudi Arabia: A Cross-Sectional Study.
    Alanzi ME; Alghamdi RA; Alsharif OM; Alghamdi KS; El Sayed SM
    J Cosmet Sci; 2018; 69(2):101-120. PubMed ID: 29799808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misuse of topical corticosteroids: a clinical study in an Iraqi hospital.
    Al-Dhalimi MA; Aljawahiry N
    East Mediterr Health J; 2006 Nov; 12(6):847-52. PubMed ID: 17333832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The widespread use of skin lightening creams in Senegal: a persistent public health problem in West Africa.
    del Giudice P; Yves P
    Int J Dermatol; 2002 Feb; 41(2):69-72. PubMed ID: 11982639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misuse of topical corticosteroids on facial skin. A study of 200 patients.
    Sharma R; Abrol S; Wani M
    J Dermatol Case Rep; 2017 Mar; 11(1):5-8. PubMed ID: 28539982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous inflammatory acne due to combined application of cosmetic and facial rubbing.
    Seneschal J; Kubica E; Boursault L; Stokkermans J; Labreze C; Milpied B; Ezzedine K; Taïeb A
    Dermatology; 2012; 224(3):221-3. PubMed ID: 22653048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography.
    Dall' Oglio F; Tedeschi A; Fusto CM; Lacarrubba F; Dinotta F; Micali G
    G Ital Dermatol Venereol; 2017 Oct; 152(5):436-440. PubMed ID: 28121079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use and abuse of topical corticosteroids in dermatology.
    Hallam NF
    Scott Med J; 1980 Oct; 25(4):287-91. PubMed ID: 7209503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Usage of Hypoallergenic Cosmetics in Patients with Atopic Dermatitis.
    Zeljko Penavić J; Šimić D; Petrušić I; Kraljević M; Sulić AM
    Acta Dermatovenerol Croat; 2018 Jun; 26(2):105-108. PubMed ID: 29989865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misuse of Topical Corticosteroids in Dermatological Disorders in Tribhuvan University Teaching Hospital.
    Chudal D; Paudel V
    J Nepal Health Res Counc; 2021 Jan; 18(4):729-733. PubMed ID: 33510519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cosmetics and topical medications in acne: Where is the boundary?].
    Poli F; Claudel JP; Auffret N; Leccia MT; Dréno B
    Ann Dermatol Venereol; 2017 Dec; 144(12):768-775. PubMed ID: 28993016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reasons for consulting related to skin-bleaching products used by 104 women in Brazzaville].
    Gathse A; Obengui ; Ibara JR
    Bull Soc Pathol Exot; 2005 Dec; 98(5):387-9. PubMed ID: 16425720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.